Paroxysmal hypertension during L-dopa treatment in parkinsonism: a metabolic error or a pharmacological effect?
D000368:Aged; D002395:Catecholamines / Q000652:urine; D004295:Dihydroxyphenylalanine / Q000009:adverse effects* / Q000378:metabolism / Q000627:therapeutic use; D004837:Epinephrine / Q000652:urine; D005260:Female; D006801:Humans; D006973:Hypertension / Q000139:chemically induced*; D008661:Metabolism, Inborn Errors / Q000175:diagnosis*; D008875:Middle Aged; D009474:Neurons / Q000378:metabolism; D009638:Norepinephrine / Q000096:biosynthesis / Q000652:urine; D010300:Parkinson Disease / Q000188:drug therapy*
D002395:Catecholamines; D004295:Dihydroxyphenylalanine; D009638:Norepinephrine; D004837:Epinephrine